002082.SZ · ST万邦
China A-shares · RS rating 64 · As of 2026-10-14
| Price | 12.38 CNY |
|---|---|
| 1-day change | -4.5% |
| RS rating (overall / 1M / 3M / 12M) | 64 / 98 / 53 / 79 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 26 / 21 / 13 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -42.6% |
| Distance from 52-week high | +65.8% |
| Market cap (USD) | $1.2B |